Literature DB >> 30375535

Presarcopenia and its Impact on Disability in Female Patients With Rheumatoid Arthritis.

Meltem Alkan Melikoğlu1.   

Abstract

OBJECTIVES: This cross-sectional pilot study aims to investigate presarcopenia in female patients with rheumatoid arthritis (RA) and to evaluate its relationship to the disability assessment. PATIENTS AND METHODS: Forty female patients with RA (mean age 48.29±8.34; range 31 to 66 years) and 40 healthy controls (mean age 46.21±6.90; range 31 to 58 years) matched for age, sex, and body mass index were included. Pain, morning stiffness duration, disease activity score, erythrocyte sedimentation rate, C-reactive protein, and Health Assessment Questionnaire (HAQ) were evaluated. Body compositions were assessed with whole body dual energy X-ray absorptiometry. The appendicular skeletal muscle mass and skeletal muscle mass index (SMI) of RA patients were compared to the controls and possible correlations between SMI, disease characteristics, and HAQ score were investigated.
RESULTS: The body mass index values and percentages of obese, overweight, and healthy weight subjects were similar in the patient and control groups. However, appendicular skeletal muscle mass and SMI calculations were significantly lower, and the percentage of presarcopenia was significantly higher in patients with RA (20%) than controls (7%) (p<0.05). Although there was no significant correlation between SMI and other parameters, a significant negative correlation was determined between SMI and HAQ score in patients with RA (p<0.05).
CONCLUSION: We demonstrated lower SMI values and higher presarcopenia ratios in patients with RA than healthy controls. Independent from other disease characteristics, the inverse correlation between SMI and HAQ scores may contribute to understanding of the impact of the process on patient disability.

Entities:  

Keywords:  Disability; presarcopenia; rheumatoid arthritis; sarcopenia

Year:  2017        PMID: 30375535      PMCID: PMC6190944          DOI: 10.5606/ArchRheumatol.2017.6078

Source DB:  PubMed          Journal:  Arch Rheumatol        ISSN: 2148-5046            Impact factor:   1.472


  23 in total

1.  Appendicular lean tissue mass and the prevalence of sarcopenia among healthy women.

Authors:  László B Tankó; Lusine Movsesyan; Ulrik Mouritzen; Claus Christiansen; Ole L Svendsen
Journal:  Metabolism       Date:  2002-01       Impact factor: 8.694

2.  Issues in cross-cultural validity: example from the adaptation, reliability, and validity testing of a Turkish version of the Stanford Health Assessment Questionnaire.

Authors:  Ayse A Küçükdeveci; Hülya Sahin; Sebnem Ataman; Bridget Griffiths; Alan Tennant
Journal:  Arthritis Rheum       Date:  2004-02-15

3.  Physical activity is negatively associated with the metabolic syndrome in the elderly.

Authors:  G Bianchi; V Rossi; A Muscari; D Magalotti; M Zoli
Journal:  QJM       Date:  2008-07-23

4.  Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.

Authors:  M L Prevoo; M A van 't Hof; H H Kuper; M A van Leeuwen; L B van de Putte; P L van Riel
Journal:  Arthritis Rheum       Date:  1995-01

Review 5.  Mechanisms of muscle wasting in sarcopenia.

Authors:  Vivian de Oliveira Nunes Teixeira; Lidiane Isabel Filippin; Ricardo Machado Xavier
Journal:  Rev Bras Reumatol       Date:  2012 Mar-Apr

6.  Early rheumatoid arthritis and body composition.

Authors:  Christina Book; Magnus K Karlsson; Kristina Akesson; Lennart T H Jacobsson
Journal:  Rheumatology (Oxford)       Date:  2009-07-13       Impact factor: 7.580

7.  Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People.

Authors:  Alfonso J Cruz-Jentoft; Jean Pierre Baeyens; Jürgen M Bauer; Yves Boirie; Tommy Cederholm; Francesco Landi; Finbarr C Martin; Jean-Pierre Michel; Yves Rolland; Stéphane M Schneider; Eva Topinková; Maurits Vandewoude; Mauro Zamboni
Journal:  Age Ageing       Date:  2010-04-13       Impact factor: 10.668

8.  Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics".

Authors:  M Muscaritoli; S D Anker; J Argilés; Z Aversa; J M Bauer; G Biolo; Y Boirie; I Bosaeus; T Cederholm; P Costelli; K C Fearon; A Laviano; M Maggio; F Rossi Fanelli; S M Schneider; A Schols; C C Sieber
Journal:  Clin Nutr       Date:  2010-01-08       Impact factor: 7.324

9.  The clinical value of the Stanford Health Assessment Questionnaire Functional Disability Index in patients with rheumatoid arthritis.

Authors:  F Wolfe; S M Kleinheksel; M A Cathey; D J Hawley; P W Spitz; J F Fries
Journal:  J Rheumatol       Date:  1988-10       Impact factor: 4.666

10.  Skeletal muscle mass adjusted by height correlated better with muscular functions than that adjusted by body weight in defining sarcopenia.

Authors:  Der-Sheng Han; Ke-Vin Chang; Chia-Ming Li; Yu-Hong Lin; Tung-Wei Kao; Keh-Sung Tsai; Tyng-Grey Wang; Wei-Shiung Yang
Journal:  Sci Rep       Date:  2016-01-20       Impact factor: 4.379

View more
  6 in total

Review 1.  Prevalence of Sarcopenia and its Association with Antirheumatic Drugs in Middle-Aged and Older Adults with Rheumatoid Arthritis: A Systematic Review and Meta-analysis.

Authors:  Thang Dao; Ben Kirk; Steven Phu; Sara Vogrin; Gustavo Duque
Journal:  Calcif Tissue Int       Date:  2021-06-16       Impact factor: 4.333

2.  Sarcopenia in Patients with Rheumatic Diseases: Prevalence and Associated Risk Factors.

Authors:  Michele Barone; Maria Teresa Viggiani; Maria Grazia Anelli; Rosalinda Fanizzi; Orsola Lorusso; Giuseppe Lopalco; Luca Cantarini; Alfredo Di Leo; Giovanni Lapadula; Florenzo Iannone
Journal:  J Clin Med       Date:  2018-12-01       Impact factor: 4.241

Review 3.  Prevalence of depression in patients with sarcopenia and correlation between the two diseases: systematic review and meta-analysis.

Authors:  Zhenzhen Li; Xiang Tong; Yao Ma; Ting Bao; Jirong Yue
Journal:  J Cachexia Sarcopenia Muscle       Date:  2022-01-08       Impact factor: 12.063

4.  Prevalence of sarcopenia in patients with rheumatoid arthritis using the revised EWGSOP2 and the FNIH definition.

Authors:  Roswitha Dietzel; Sabine Wiegmann; Diana Borucki; Christian Detzer; Kim Nikola Zeiner; Désirée Schaumburg; Bjoern Buehring; Frank Buttgereit; Gabriele Armbrecht
Journal:  RMD Open       Date:  2022-09

5.  An association analysis between hypertension, dementia, and depression and the phases of pre-sarcopenia to sarcopenia: A cross-sectional analysis.

Authors:  Takeshi Endo; Kenju Akai; Tsunetaka Kijima; Shigetaka Kitahara; Takafumi Abe; Miwako Takeda; Toru Nabika; Shozo Yano; Minoru Isomura
Journal:  PLoS One       Date:  2021-07-22       Impact factor: 3.240

Review 6.  Sarcopenia in Autoimmune and Rheumatic Diseases: A Comprehensive Review.

Authors:  Hyo Jin An; Kalthoum Tizaoui; Salvatore Terrazzino; Sarah Cargnin; Keum Hwa Lee; Seoung Wan Nam; Jae Seok Kim; Jae Won Yang; Jun Young Lee; Lee Smith; Ai Koyanagi; Louis Jacob; Han Li; Jae Il Shin; Andreas Kronbichler
Journal:  Int J Mol Sci       Date:  2020-08-07       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.